| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.03 |